← Back to headlines
Novo Nordisk's head of research has his sights set on a new pill that "to a great extent" can beat competitors in weight loss
Right now, the Wegovy pill is surging in the USA. At the same time, Novo Nordisk is testing a new pill which, according to head of research Martin Holst Lange, has the potential to sweep all future pill competitors off the market.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
